1-3 of 3
Maria Christina Kyrtsonis, MD
Close
Sort by
Journal Articles

Topoisomerase IIα (TopoIIα) Expression in Hodgkin’s Lymphoma (HL): Correlations with Conventional and Biological Markers and Prognostic Significance under Treatment with ABVD or Equivalent Regimens with or without Radiotherapy (RT).

Theodoros P. Vassilakopoulos, MD, Ipatia A. Doussis-Anagnostopoulou, MD, Despina Karandrea, Penelope Korkolopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria N. Dimopoulou, MD, Christina Kalpadaki, MD, Maria-Christina Kyrtsonis, MD, Irini Thymara, MD, Nikolaos Kavantzas, MD, Panayiotis Panayiotidis, MD, Efstratios Patsouris, MD, Christos Kittas, MD, Gerassimos A. Pangalis, MD
Journal: Blood
Blood (2005) 106 (11): 967.
https://doi.org/10.1182/blood.V106.11.967.967
Published: 2005
Journal Articles

Primary Treatment with Pulsed Melphalan, Dexamethasone, Thalidomide (MDT) for Symptomatic Patients with Multiple Myeloma ≥ 75 Years of Age.

Meletios A. Dimopoulos, MD, Panagiotis Repoussis, MD, Evangelos Terpos, MD, Maria Christina Kyrtsonis, MD, Athanasios Zomas, MD, Eirini Katodritou, MD, Souzana Delibasi, MD, Amalia Vassou, MD, Athanasios Anagnostopoulos, MD, Anastasia Pouli, MD, Konstantinos Zervas, MD, Dimitrios Margaritis, MD, Nikolaos Anagnostopoulos, MD, Alice G. Maniatis, MD
Journal: Blood
Blood (2004) 104 (11): 1482.
https://doi.org/10.1182/blood.V104.11.1482.1482
Published: 2004
Journal Articles

Primary Treatment of Waldenstrom’s Macroglobulinemia (WM) with Dexamethasone, Rituximab and Cyclophosphamide.

Meletios A. Dimopoulos, MD, Maria Christina Kyrtsonis, MD, Constantinos Tsatalas, MD, Garyfallia Kokkini, MD, Panagiotis Repoussis, MD, Athanasios Zomas, MD, Argiris Symeonidis, MD, Evridiki Michali, MD, Athanasios Anagnostopoulos, MD, Nikolaos Anagnostopoulos, MD, Theophanis Economopoulos, MD, Gerasimos Pangalis, MD
Journal: Blood
Blood (2004) 104 (11): 752.
https://doi.org/10.1182/blood.V104.11.752.752
Published: 2004